Tirzepatide offers a potential way through that plateau because it targets a second hormone receptor that semaglutide does not touch
GLP-1 receptor agonists stimulate insulin secretion from pancreatic beta cells in a glucose-dependent manner, meaning they promote insulin release primarily when blood glucose levels are elevated
Like orforglipron, these occur most frequently during dose titration and tend to improve over time
Fat loss in the middle of the face can lead to flattening and hollowing of the cheeks, deepening of the nasolabial folds and downward migration of facial tissues
Tumor necrosis factor-alpha was increased in the livers of AF mice, while expression of the anti-inflammatory cytokine interleukin-10 was increased in the livers of AF + P mice, confirming the anti-inflammatory properties of L3B2 administration 17
Unlike hGH, which carries broader systemic effects and risks associated with elevated IGF-1 levels, AOD9604 appears to selectively promote fat metabolism without triggering growth-related side effects, suggesting its potential as a safer therapeutic candidate for obesity and metabolic disorders [2]
